Quick Answer
Definium Therapeutics, Inc. reported Net Income of -$183.79 million for fiscal year 2025.
Definium Therapeutics, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$183.79M | -69.1% |
| 2024 | -$108.68M | -13.5% |
| 2023 | -$95.73M | -68.6% |
| 2022 | -$56.80M | +39.0% |
| 2021 | -$93.04M | -174.1% |
| 2020 | -$33.94M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$67.27M | -391.6% | -57.4% |
| June 30, 2025 | -$42.74M | -630.2% | -83.1% |
| March 31, 2025 | -$23.35M | +57.1% | -70.6% |
| September 30, 2024 | -$13.68M | +23.7% | -133.8% |
| June 30, 2024 | -$5.85M | +79.9% | +89.2% |
| March 31, 2024 | -$54.40M | -119.2% | -203.5% |
| September 30, 2023 | -$17.92M | -8.7% | +38.5% |
| June 30, 2023 | -$29.13M | -71.8% | -17.4% |
- Definium Therapeutics, Inc. showed a decrease of -69.1% in Net Income compared to the prior fiscal year.
- Over the 2020–2025 period, Definium Therapeutics, Inc.’s net income has declined by 441.6% (from -$33.94 million to -$183.79 million).
- The most recent figure is from Definium Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: